InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Adams Kendra, Chief Financial Officer. Officer active across 1 company, notably C4 Therapeutics, Inc.. Aggregated, 12 disclosures have been published. Activity tracked since 18 September 2023. The latest transaction was filed on 13 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Adams Kendra
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
240,000 shares0Common StockSEC:0001470831-26-000175:0
6,250 shares0Common StockSEC:0001470831-25-000223:0
1,863 shares@ US$3.2012.0% of flowCommon StockSEC:0001662579-25-000016:0
4,559 shares@ US$3.1828.9% of flowCommon StockSEC:0001662579-25-000016:2
87,100 shares0Common StockSEC:0001662579-25-000016:1
3,750 sharesCommon StockSEC:0001662579-24-000103:0
1,102 shares@ US$6.0412.9% of flowCommon StockSEC:0001662579-24-000103:1
1,837 shares@ US$6.3822.0% of flowCommon StockSEC:0001662579-24-000086:0
661 shares@ US$6.367.9% of flowCommon StockSEC:0001662579-24-000082:1
2,250 sharesCommon StockSEC:0001662579-24-000082:0
1,301 shares@ US$6.5316.4% of flowCommon StockSEC:0001662579-24-000014:0
25,000 shares0Common StockSEC:0001662579-23-000097:0
12 of 12 declarations
About Adams Kendra
Adams Kendra is the Chief Financial Officer at C4 Therapeutics, Inc. In this role, she is responsible for the company's financial management, including budgeting and financial analysis. Her expertise is crucial in ensuring the financial health of the organization.
